Eli Lilly has been making quite a bit of noise thanks to its work in diabetes and obesity ... Regeneron also recently lost a ...

An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...

HYDERABAD: IT and Industries Minister D Sridhar Babu on Thursday announced that the Congress government has secured ...

Residents in more rural communities of New Hampshire will soon have access to ultra-high-capacity, high-speed broadband technology, thanks to the launch of Trailrunner Broadband's upgraded high-speed ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Regulators are reviewing what could become a multi-billion-dollar drug.

Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, today announced ...

Shares of biopharma companies levered to COVID-19 vaccines tumbled on Thursday after President-elect Donald Trump picked ...

RSV symptoms include cough, fever, running nose, irritability, reduced activity, and pauses in breathing. Severe cases can ...

Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug from China's LaNova Medicines.Please watch the video at Investors.com - ...